Literature DB >> 20673709

UK guidelines for the safe delivery of intensity-modulated radiotherapy.

R I MacKay1, J Staffurth, A Poynter, D Routsis.   

Abstract

This paper outlines the guidelines for the development of intensity-modulated radiotherapy (IMRT) in the UK. The guidelines are designed to cover the complete implementation of IMRT, with guidelines in the following categories: commissioning, quality, clinical, audit, and training and education. These guidelines have been compiled by the Radiotherapy Development Board of the Royal College of Radiologists and will support the safe application of IMRT in the UK. Copyright 2010 The Royal College of Radiologists. Published by Elsevier Ltd. All rights reserved.

Mesh:

Year:  2010        PMID: 20673709     DOI: 10.1016/j.clon.2010.06.017

Source DB:  PubMed          Journal:  Clin Oncol (R Coll Radiol)        ISSN: 0936-6555            Impact factor:   4.126


  3 in total

1.  Implementation of intensity modulated radiotherapy for prostate cancer in a private radiotherapy service in Mexico.

Authors:  María Adela Poitevin-Chacón; Gabriel Reséndiz González; Adriana Alvarado Zermeño; Jesús Manuel Flores Castro; Christian Haydée Flores Balcázar; Samuel Rosales Pérez; Miguel Angel Pérez Pastenes; Alejandro Rodríguez Laguna; Patricio Vázquez Fernández; Alejandro Calvo Fernández; Jorge Bastida Ventura
Journal:  Rep Pract Oncol Radiother       Date:  2014-12-12

2.  Multi-institutional evaluation using the end-to-end test for implementation of dynamic techniques of radiation therapy in Thailand.

Authors:  Lalida Tuntipumiamorn; Puangpen Tangboonduangjit; Taweap Sanghangthum; Rattapol Rangseevijitprapa; Chirasak Khamfongkhruea; Thida Niyomthai; Boonrut Vuttiprasertpong; Supranee Supanant; Nongnuch Chatchaipaiboon; Porntip Iampongpaiboon; Pitchayut Nakkrasae; Tanwiwat Jaikuna
Journal:  Rep Pract Oncol Radiother       Date:  2018-11-28

3.  A multi-institutional study for tolerance and action levels of IMRT dose quality assurance measurements in Korea.

Authors:  Jung-in Kim; Jin-Beom Chung; Yang-Kyun Park; Ju-Young Song; Sung Kyu Kim; Sung Hwan Ahn; Chang Heon Choi; Won Hoon Choi; Byungchul Cho; Sang Gyu Ju; Sung Jin Kim; Sung-Joon Ye
Journal:  J Appl Clin Med Phys       Date:  2013-03-04       Impact factor: 2.102

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.